These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29321438)

  • 1. Vogt-Koyanagi-Harada Disease Associated with Influenza A Virus Infection.
    Yoshino N; Kawamura A; Ishii A; Yoshida K; Watanabe T; Yamashita T; Fukuchi T; Toyoda F; Kakehashi A; Sugawara H
    Intern Med; 2018 Jun; 57(11):1661-1665. PubMed ID: 29321438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of pulse corticosteroid therapy for vogt-koyanagi-harada disease assessed by optical coherence tomography.
    Yamanaka E; Ohguro N; Yamamoto S; Nakagawa Y; Imoto Y; Tano Y
    Am J Ophthalmol; 2002 Sep; 134(3):454-6. PubMed ID: 12208266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical difluprednate for treatment of serous retinal detachment and panuveitis associated with Vogt-Koyanagi-Harada disease.
    Lu S; Taban M
    Digit J Ophthalmol; 2016; 22(2):54-7. PubMed ID: 27582676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BACILLARY LAYER DETACHMENT IN ACUTE VOGT-KOYANAGI-HARADA DISEASE: A Novel Swept-Source Optical Coherence Tomography Analysis.
    Agarwal A; Freund KB; Kumar A; Aggarwal K; Sharma D; Katoch D; Bansal R; Gupta V;
    Retina; 2021 Apr; 41(4):774-783. PubMed ID: 32833410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vogt-Koyanagi-Harada Syndrome following influenza vaccination.
    Kim M
    Indian J Ophthalmol; 2016 Jan; 64(1):98. PubMed ID: 26953036
    [No Abstract]   [Full Text] [Related]  

  • 6. Vogt-Koyanagi-Harada disease after stapedotomy.
    Accorinti M; Gilardi M; Nardella C; Amorelli GM; Pesci FR
    Eur J Ophthalmol; 2015 Oct; 25(6):e127-30. PubMed ID: 25982211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vogt-Koyanagi-Harada syndrome in a 4-year-old child.
    Gruich MJ; Evans OB; Storey JM; Bradley ST; Chen CJ
    Pediatr Neurol; 1995 Jul; 13(1):50-1. PubMed ID: 7575849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
    Andrade RE; Muccioli C; Farah ME; Nussenblatt RB; Belfort R
    Am J Ophthalmol; 2004 Mar; 137(3):572-4. PubMed ID: 15013890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute lymphoblastic leukemia manifesting as acute Vogt-Koyanagi-Harada disease.
    Yang HK; Yu HG
    Korean J Ophthalmol; 2009 Dec; 23(4):325-8. PubMed ID: 20046700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral dexamethasone intravitreal implant in a young patient with Vogt-Koyanagi-Harada disease and refractory uveitis.
    Latronico ME; Rigante D; Caso F; Cantarini L; Costa L; Nieves-Martín L; Traversi C; Franceschini R
    Clin Rheumatol; 2015 Jun; 34(6):1145-8. PubMed ID: 24763751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vogt-Koyanagi-Harada syndrome associated with bilateral serous macular detachments responsive to immunomodulatory therapy.
    Gallagher MJ; Yilmaz T; Foster CS
    Ophthalmic Surg Lasers Imaging; 2009; 40(3):345-7. PubMed ID: 19485308
    [No Abstract]   [Full Text] [Related]  

  • 12. Vogt-Koyanagi-Harada disease in 3-year-old boy.
    Takada S; Tanaka R; Kurita N; Ishii K; Kaburaki T
    Clin Exp Ophthalmol; 2015 Aug; 43(6):593-4. PubMed ID: 25711345
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of pulse steroid treatment of ten days' long on the improvement of bacillary layer detachment in a patient with Vogt-Koyanagi Harada disease.
    Atas F; Kaya M; Saatci AO
    Rom J Ophthalmol; 2021; 65(2):183-186. PubMed ID: 34179585
    [No Abstract]   [Full Text] [Related]  

  • 14. Serous Macular Detachment in Probable Vogt-Koyanagi-Harada Syndrome.
    Li AS; Tang PH; Do DV
    JAMA Ophthalmol; 2020 May; 138(5):e191981. PubMed ID: 32407448
    [No Abstract]   [Full Text] [Related]  

  • 15. Tomographic features of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
    Maruyama Y; Kishi S
    Ophthalmic Surg Lasers Imaging; 2004; 35(3):239-42. PubMed ID: 15185793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and visual outcomes of 111 patients with new-onset acute Vogt-Koyanagi-Harada disease treated with pulse intravenous corticosteroids.
    Nakayama M; Keino H; Watanabe T; Okada AA
    Br J Ophthalmol; 2019 Feb; 103(2):274-278. PubMed ID: 29666121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RETINAL PIGMENT EPITHELIUM UNDULATIONS IN ACUTE STAGE OF VOGT-KOYANAGI-HARADA DISEASE: Biomarker for Functional Outcomes After High-Dose Steroid Therapy.
    Hashizume K; Imamura Y; Fujiwara T; Machida S; Ishida M; Kurosaka D
    Retina; 2016 Feb; 36(2):415-21. PubMed ID: 26352553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case presentation of an IgA nephropathy patient with Vogt-Koyanagi-Harada syndrome.
    Zhang Q; Fan X; Tian M; Han H
    BMC Nephrol; 2020 Jul; 21(1):272. PubMed ID: 32660433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progresses and existed problems on the diagnosis and treatment of Vogt-Koyanagi-Harada disease].
    Zheng YZ
    Zhonghua Yan Ke Za Zhi; 2012 Jun; 48(6):572-6. PubMed ID: 22943816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect on choroidal changes of the route of systemic corticosteroids in acute Vogt-Koyanagi-Harada disease.
    Park UC; Cho IH; Lee EK; Yu HG
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1203-1211. PubMed ID: 28382438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.